  0 Table of Contents |
  1 Home |
| 2 Workflow |
| 3 CVD Report |
| 4 Profiles |
| 5 Terminology |
| 6 Examples |
| 7 Questionnaires |
 8 Artifacts Summary |
 8.1 Ankle-Brachial Index (ABI) |
| 8.2 Arterial Stiffness (PWV) |
| 8.3 Care Plan: CVD prevention measures (LT) |
| 8.4 Carotid Ultrasound |
| 8.5 Composition: CVD programme document (LT) |
| 8.6 Coronary Artery Calcium Score (Agatston) |
| 8.7 CVD High Risk Condition |
| 8.8 CVD Risk Group |
| 8.9 DiagnosticReport: CVD programme report (LT) |
| 8.10 Echocardiography |
| 8.11 EKG |
| 8.12 Risk Factor Status |
| 8.13 SCORE2. General Assessment of Cardiovascular Disease Risk |
| 8.14 CVD Risk Group Extension |
| 8.15 Ankle-Brachial Index Interpretation |
| 8.16 Arterial Stiffness Interpretation |
| 8.17 Cardiovascular Disease Risk Degree (SCORE2) |
| 8.18 Cardiovascular Disease Risk Group |
| 8.19 Carotid Plaque Category |
| 8.20 Coronary Artery Calcium Score Interpretation |
| 8.21 CVD Composition Codes |
| 8.22 CVD High Risk Conditions |
| 8.23 Ejection Fraction Category |
| 8.24 EKG Result Interpretation |
| 8.25 Risk Factor Type |
| 8.26 ABI Component |
| 8.27 Ankle-Brachial Index Interpretation |
| 8.28 Carotid Plaque Category |
| 8.29 Carotid Ultrasound Component |
| 8.30 Coronary Artery Calcium Score Interpretation |
| 8.31 CVD prevention plan questionnaire item (linkId) |
| 8.32 CVD questionnaire mapping target (profiles) |
| 8.33 CVD risk assessment questionnaire item (linkId) |
| 8.34 Ejection Fraction Category |
| 8.35 CVD prevention plan Questionnaire item → profile mapping |
| 8.36 CVD risk assessment Questionnaire item → profile mapping |
| 8.37 Care Plan: CVD Screening (example) |
| 8.38 Care Plan: ŠKL prevention plan (SKL02) |
| 8.39 Care Plan: ŠKL progress assessment (SKL03) |
| 8.40 CarePlan: CVD Screening with External Goals (example) |
| 8.41 CarePlan: CVD Screening with Inline Goals (example) |
| 8.42 Composition: CVD programme document (example) |
| 8.43 Composition: CVD Risk Assessment (EU IM style, cross-IG examples) |
| 8.44 Composition: ŠKL Plan of care (SKL02) |
| 8.45 Composition: ŠKL Progress note (SKL03) |
| 8.46 Composition: ŠKL Risk Assessment (SKL01 format) |
| 8.47 Composition: ŠKL Risk Assessment (SKL01) |
| 8.48 Condition: CVD Heart Failure (example) |
| 8.49 Condition: DSTU1 Legacy chronic condition (id:351) |
| 8.50 DiagnosticReport: CVD programme report (example) |
| 8.51 Encounter: DSTU1 Legacy (id:1000017570) |
| 8.52 Goal: Blood Pressure (example) |
| 8.53 Goal: Body Mass Index (example) |
| 8.54 Goal: LDL Cholesterol (example) |
| 8.55 List: Concomitant risk factors (SKL01) |
| 8.56 List: CVD risk factors (SKL01) |
| 8.57 List: Medication dispensed (SKL01) |
| 8.58 List: Past and current chronic diseases (SKL01) |
| 8.59 List: Patient medication list (SKL01) |
| 8.60 Medication: DSTU1 Legacy (id:1000017575) |
| 8.61 MedicationDispense: DSTU1 Legacy (id:1000043) |
| 8.62 MedicationStatement: Current medication (SKL01) |
| 8.63 MedicationStatement: Screening (example) |
| 8.64 Observation: Alcohol consumption (SKL01) |
| 8.65 Observation: Blood pressure panel (SKL01) |
| 8.66 Observation: Blood pressure panel (SKL03) |
| 8.67 Observation: BMI (SKL01) |
| 8.68 Observation: BMI (SKL03) |
| 8.69 Observation: Body height (SKL01) |
| 8.70 Observation: Body height (SKL03) |
| 8.71 Observation: Body weight (SKL01) |
| 8.72 Observation: Body weight (SKL03) |
| 8.73 Observation: Comment (SKL03) |
| 8.74 Observation: CVD risk group (SKL01) |
| 8.75 Observation: CVD Risk Group High (example) |
| 8.76 Observation: Diabetes Duration > 10 Years (example) |
| 8.77 Observation: Diabetes duration >10 years (SKL01) |
| 8.78 Observation: Diabetes risk factor (SKL01) |
| 8.79 Observation: Diabetes Untreated (example) |
| 8.80 Observation: Diastolic BP (SKL01) |
| 8.81 Observation: Diastolic BP (SKL03) |
| 8.82 Observation: Diet (SKL01) |
| 8.83 Observation: Dyslipidemia risk factor (SKL01) |
| 8.84 Observation: Dyslipidemia Treated (example) |
| 8.85 Observation: EKG Normal (example) |
| 8.86 Observation: Evaluation note panel (SKL01) |
| 8.87 Observation: Follow-up blood pressure (example) |
| 8.88 Observation: Follow-up LDL cholesterol (example) |
| 8.89 Observation: Heart rate (SKL01) |
| 8.90 Observation: Hypertension Negligible Risk (example) |
| 8.91 Observation: Hypertension risk factor (SKL01) |
| 8.92 Observation: Impaired Glucose Tolerance (example) |
| 8.93 Observation: Impaired glucose tolerance (SKL01) |
| 8.94 Observation: Laboratory studies panel (SKL01) |
| 8.95 Observation: Laboratory studies panel (SKL03) |
| 8.96 Observation: LDL cholesterol (SKL01) |
| 8.97 Observation: LDL cholesterol (SKL03) |
| 8.98 Observation: Metabolic syndrome (SKL01) |
| 8.99 Observation: Other recommendations (SKL02) |
| 8.100 Observation: Overweight or obesity (SKL01) |
| 8.101 Observation: Physical activity (SKL01) |
| 8.102 Observation: SCORE2 (SKL01) |
| 8.103 Observation: SCORE2 Cardiovascular Disease Risk Assessment (example) |
| 8.104 Observation: Smoking risk factor (SKL01) |
| 8.105 Observation: Systolic BP (SKL01) |
| 8.106 Observation: Systolic BP (SKL03) |
| 8.107 Observation: Total cholesterol (SKL01) |
| 8.108 Observation: Treatment status (SKL01) |
| 8.109 Observation: Venous glucose (SKL01) |
| 8.110 Observation: Vital signs panel (SKL01) |
| 8.111 Observation: Vital signs panel (SKL03) |
| 8.112 Observation: Waist circumference (SKL01) |
| 8.113 Observation: Weight at first visit (SKL03) |
| 8.114 Organization: Vilniaus miesto ligoninė (example) |
| 8.115 Patient: Jonas Petrauskas (example) |
| 8.116 Practitioner: Dr. Petras Kazlauskas (example) |
| 8.117 PractitionerRole: Dr. Petras Kazlauskas at Vilniaus miesto ligoninė (example) |
| 8.118 Questionnaire: CVD prevention plan and achievement (ESPBI form 2) |
| 8.119 Questionnaire: CVD risk assessment (ESPBI form 1) |
| 8.120 QuestionnaireResponse: CVD prevention plan and achievement (example) |
 8.121 QuestionnaireResponse: CVD risk assessment (example) |
